Anne Girault1, Marie Ferrua2, Benoît Lalloué3, Claude Sicotte4, Aude Fourcade5, Fatima Yatim6, Guillaume Hébert7, Mario Di Palma8, Etienne Minvielle9. 1. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France; EA 7348 MOS (Management des organisations de santé), Ecole des Hautes Etudes en Santé Publique, Bâtiment LERICHE - 96 rue didot Paris, France. Electronic address: anne.girault@ehesp.fr. 2. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France. Electronic address: marie.ferrua@gustaveroussy.fr. 3. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France. Electronic address: benoit.lalloue@gustaveroussy.fr. 4. EA 7348 MOS (Management des organisations de santé), Ecole des Hautes Etudes en Santé Publique, Bâtiment LERICHE - 96 rue didot Paris, France; Université de Montreal, Montreal, QC, Canada. Electronic address: claude.sicotte@umontreal.ca. 5. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France. Electronic address: aude.fourcade@gustaveroussy.fr. 6. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France; EA 7348 MOS (Management des organisations de santé), Ecole des Hautes Etudes en Santé Publique, Bâtiment LERICHE - 96 rue didot Paris, France. Electronic address: FATIMA.DAUMAS-YATIM@gustaveroussy.fr. 7. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France; EA 7348 MOS (Management des organisations de santé), Ecole des Hautes Etudes en Santé Publique, Bâtiment LERICHE - 96 rue didot Paris, France. Electronic address: guillaume.hebert@gustaveroussy.fr. 8. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France. Electronic address: mario.dipalma@gustaveroussy.fr. 9. Gustave Roussy, Projet CAPRI, 114 rue Edouard vaillant, Villejuif 94805, France; EA 7348 MOS (Management des organisations de santé), Ecole des Hautes Etudes en Santé Publique, Bâtiment LERICHE - 96 rue didot Paris, France. Electronic address: etienne.minvielle@gustaveroussy.fr.
Abstract
BACKGROUND: The uses of internet-based technologies (e.g. patient portals, websites and applications) by cancer patients could be strong drive for change in cancer care coordination practices. The goal of this study was to assess the current utilisation of internet-based technologies (IBT) among cancer patients, and their willingness to use them for their health, as well as analyse the influence of socio-demographics on both aspects. METHODS: A questionnaire-based survey was conducted in June 2013, over seven non-consecutive days within seven outpatient departments of Gustave Roussy, a comprehensive cancer centre (≈160,000 consultations yearly), located just outside Paris. We computed descriptive statistics and performed correlation analysis to investigate patients' usage and attitudes in correspondence with age, gender, socioeconomic status, social isolation, and place of living. We then conducted multinomial logistic regressions using R. RESULTS: The participation level was 85% (n=1371). The median age was 53.4. 71% used a mobile phone everyday and 93% had access to Internet from home. Age and socioeconomic status were negatively associated with the use of IBT (p<0.001). Regarding patients' expected benefits, a wide majority valued its use in health care, and especially, the possibility to enhance communication with providers. 84% of patients reported feeling comfortable with the use of such technologies but age and socioeconomic status had a significant influence. CONCLUSION: Most patients used IBTs every day. Overall, patients advocated for an extended use of IBT in oncology. Differences in perceived ease of use corresponding to age and socioeconomic status have to be addressed.
BACKGROUND: The uses of internet-based technologies (e.g. patient portals, websites and applications) by cancerpatients could be strong drive for change in cancer care coordination practices. The goal of this study was to assess the current utilisation of internet-based technologies (IBT) among cancerpatients, and their willingness to use them for their health, as well as analyse the influence of socio-demographics on both aspects. METHODS: A questionnaire-based survey was conducted in June 2013, over seven non-consecutive days within seven outpatient departments of Gustave Roussy, a comprehensive cancer centre (≈160,000 consultations yearly), located just outside Paris. We computed descriptive statistics and performed correlation analysis to investigate patients' usage and attitudes in correspondence with age, gender, socioeconomic status, social isolation, and place of living. We then conducted multinomial logistic regressions using R. RESULTS: The participation level was 85% (n=1371). The median age was 53.4. 71% used a mobile phone everyday and 93% had access to Internet from home. Age and socioeconomic status were negatively associated with the use of IBT (p<0.001). Regarding patients' expected benefits, a wide majority valued its use in health care, and especially, the possibility to enhance communication with providers. 84% of patients reported feeling comfortable with the use of such technologies but age and socioeconomic status had a significant influence. CONCLUSION: Most patients used IBTs every day. Overall, patients advocated for an extended use of IBT in oncology. Differences in perceived ease of use corresponding to age and socioeconomic status have to be addressed.
Authors: Kelvin K Pho; Rong Lu; Samantha Gates; Jennifer Cai; Donglu Xie; Yang Xie; Simon J Craddock Lee; David E Gerber Journal: JCO Clin Cancer Inform Date: 2019-02
Authors: Olivier Mir; Marie Ferrua; Aude Fourcade; Delphine Mathivon; Adeline Duflot-Boukobza; Sarah Dumont; Eric Baudin; Suzette Delaloge; David Malka; Laurence Albiges; Patricia Pautier; Caroline Robert; David Planchard; Stéphane de Botton; Florian Scotté; François Lemare; May Abbas; Marilène Guillet; Vanessa Puglisi; Mario Di Palma; Etienne Minvielle Journal: Nat Med Date: 2022-04-25 Impact factor: 87.241
Authors: Carlos A Munoz-Zuluaga; José David Gallo-Pérez; Andrés Pérez-Bustos; Mavalynne Orozco-Urdaneta; Karen Druffel; Lida P Cordoba-Astudillo; Luis G Parra-Lara; Carolina Velez-Mejia; Farah El-Sharkawy; Katherin Zambrano-Vera; Raúl H Erazo; Mary C King; Armando Sardi Journal: JCO Oncol Pract Date: 2021-01-08
Authors: C Font; F Fernández-Avilés; C Calderon; T García-Fernández; N Arab; E Pineda; E Buxó; P Ayora; M Carreño; V Pereira; M Viladot; C Moreno; C Gallego; A Hernando; N Creus; C Barrera; R Alcaraz; J Sanchez; A Prat; A Tuca Journal: Support Care Cancer Date: 2015-11-10 Impact factor: 3.359
Authors: Susanne Mattsson; Erik Martin Gustaf Olsson; Sven Alfonsson; Birgitta Johansson; Maria Carlsson Journal: J Med Internet Res Date: 2015-11-20 Impact factor: 5.428